Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5244]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in...
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019
RET inhibition in RET aberrant cancers
Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA
RET inhibition in RET aberrant cancers ( Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019
A precision medicine approach to therapeutic resistance using KEAP1 somatic...
Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada
A precision medicine approach to therapeutic resistance using KEAP1 somatic mutations ( Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada )
10 Jul 2019
Direct targeting of STAT3 alone and in combination with immune checkpoint...
Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston...
Direct targeting of STAT3 alone and in combination with immune checkpoint inhibitors to treat solid tumours ( Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019
Comment: POLO III trial for metastatic pancreatic cancer
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: POLO III trial for metastatic pancreatic cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
24 Jun 2019
How will ASCO combat cancer disparities?
Dr Eduardo Cazap, Dr Richard Schilsky
How will ASCO combat cancer disparities? ( Dr Eduardo Cazap, Dr Richard Schilsky )
21 Jun 2019
Chemotherapy-free strategies in treating leukaemia
Prof Robin Foa - University of Rome, Rome, Italy
Chemotherapy-free strategies in treating leukaemia ( Prof Robin Foa - University of Rome, Rome, Italy )
20 Jun 2019
Dasatinib-blinatumomab combination for the front-line treatment of adult Ph...
Prof Robin Foa - University of Rome, Rome, Italy
Dasatinib-blinatumomab combination for the front-line treatment of adult Ph-positive ALL patients ( Prof Robin Foa - University of Rome, Rome, Italy )
20 Jun 2019
Dose escalation of REGN1979 in patients with relapsed and refractory B-NHL
Prof Max Topp - University of Würzburg, Würzburg, Germany
Dose escalation of REGN1979 in patients with relapsed and refractory B-NHL ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
20 Jun 2019
CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T...
Dr Michaela Kotrova - Universitätsklinikum Schleswig-Holstein, Kiel, Germany
CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T-cell therapy ( Dr Michaela Kotrova - Universitätsklinikum Schleswig-Holstein, Kiel, Germany )
20 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation